Complement Factor H (CFH) is a pivotal regulator of the complement system, integral to maintaining immune homeostasis and protecting host tissues from undue complement‐mediated damage. By inhibiting ...

New research finds that the complement system, part of the body’s natural immune defenses, is a key driver of inflammatory ...

The less time a tick has to feed, the less saliva it can pump in, and the fewer tricks it can use to tilt the odds. For ...

Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce ...

Aptamer Group plc has signed a new therapeutic development agreement with Invizius, a clinical-stage biotechnology company focused on second-generation complement system therapies.

Checkpoint inhibitors, such as ​​Merck’s blockbuster Keytruda and AstraZeneca’s Imfinzi, prevent cancer cells from disabling the immune response to tumours. Blyth believes Lift’s Immuno-Modulatory ...